Vaxxinity, Inc.
VAXXDelisted Apr 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851657
Vaxxinity, Inc. was delisted on Apr 29, 2024; its insiders filed their last Form 4 on Apr 29, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $8.73M in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in Vaxxinity, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VAXX is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 1
- +1 vs. Q4 2025
- Shares held
- 1.59K
- +1.59K vs. Q4 2025
- Total value
- $43
- +$43 vs. Q4 2025
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VAXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $43 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $31 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $1.42K |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 8 | $67.8K |
| Q1 2024 | 58 | $8.73M |
| Q4 2023 | 60 | $11.7M |
| Q3 2023 | 53 | $35.8M |
| Q2 2023 | 50 | $71.7M |
| Q1 2023 | 49 | $56.9M |
| Q4 2022 | 31 | $31.8M |
| Q3 2022 | 29 | $48.5M |
| Q2 2022 | 29 | $38.2M |
| Q1 2022 | 12 | $76.6M |
| Q4 2021 | 17 | $101.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Vaxxinity, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NBC Securities, Inc. | 1,592 | $43 | 0.00% | +1,592 | New |